Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 511

1.

Geographic Patterns of Growth for Transcatheter Aortic Valve Replacement in the United States.

Kundi H, Faridi KF, Wang Y, Wadhera RK, Valsdottir LR, Popma JJ, Kramer DB, Yeh RW.

Circulation. 2019 Sep 10;140(11):969-971. doi: 10.1161/CIRCULATIONAHA.119.040788. Epub 2019 Sep 9. No abstract available.

PMID:
31498696
2.

Landscape of Cardiovascular Device Registries in the United States.

Rajan PV, Holtzman JN, Kesselheim AS, Yeh RW, Kramer DB.

J Am Heart Assoc. 2019 Jun 4;8(11):e012756. doi: 10.1161/JAHA.119.012756. Epub 2019 Jun 1.

3.

Examining the Operator Learning Curve for Percutaneous Coronary Intervention of Chronic Total Occlusions.

Young MN, Secemsky EA, Kaltenbach LA, Jaffer FA, Grantham JA, Rao SV, Yeh RW.

Circ Cardiovasc Interv. 2019 Aug;12(8):e007877. doi: 10.1161/CIRCINTERVENTIONS.119.007877. Epub 2019 Aug 16.

PMID:
31416356
5.

Ad hoc percutaneous coronary intervention in patients with stable coronary artery disease: A report from the National Cardiovascular Data Registry CathPCI Registry.

Faridi KF, Rymer JA, Rao SV, Dai D, Wojdyla D, Yeh RW, Wang TY.

Am Heart J. 2019 Jul 13;216:53-61. doi: 10.1016/j.ahj.2019.07.004. [Epub ahead of print]

PMID:
31401443
6.

Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma.

Sandhu S, McNeil CM, LoRusso P, Patel MR, Kabbarah O, Li C, Sanabria S, Flanagan WM, Yeh RF, Brunstein F, Nazzal D, Hicks R, Lemahieu V, Meng R, Hamid O, Infante JR.

Invest New Drugs. 2019 Aug 5. doi: 10.1007/s10637-019-00832-1. [Epub ahead of print]

PMID:
31385109
7.

Readmission Penalties: The Authors Reply.

Ferro EG, Wadhera RK, Yeh RW.

Health Aff (Millwood). 2019 Aug;38(8):1410. doi: 10.1377/hlthaff.2019.00689. No abstract available.

PMID:
31381413
8.

Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention.

Brilakis ES, Mashayekhi K, Tsuchikane E, Abi Rafeh N, Alaswad K, Araya M, Avran A, Azzalini L, Babunashvili AM, Bayani B, Bhindi R, Boudou N, Boukhris M, Božinović NŽ, Bryniarski L, Bufe A, Buller CE, Burke MN, Büttner HJ, Cardoso P, Carlino M, Christiansen EH, Colombo A, Croce K, Damas de Los Santos F, De Martini T, Dens J, Di Mario C, Dou K, Egred M, ElGuindy AM, Escaned J, Furkalo S, Gagnor A, Galassi AR, Garbo R, Ge J, Goel PK, Goktekin O, Grancini L, Grantham JA, Hanratty C, Harb S, Harding SA, Henriques JPS, Hill JM, Jaffer FA, Jang Y, Jussila R, Kalnins A, Kalyanasundaram A, Kandzari DE, Kao HL, Karmpaliotis D, Kassem HH, Knaapen P, Kornowski R, Krestyaninov O, Kumar AVG, Laanmets P, Lamelas P, Lee SW, Lefevre T, Li Y, Lim ST, Lo S, Lombardi W, McEntegart M, Munawar M, Navarro Lecaro JA, Ngo HM, Nicholson W, Olivecrona GK, Padilla L, Postu M, Quadros A, Quesada FH, Prakasa Rao VS, Reifart N, Saghatelyan M, Santiago R, Sianos G, Smith E, C Spratt J, Stone GW, Strange JW, Tammam K, Ungi I, Vo M, Vu VH, Walsh S, Werner GS, Wollmuth JR, Wu EB, Wyman RM, Xu B, Yamane M, Ybarra LF, Yeh RW, Zhang Q, Rinfret S.

Circulation. 2019 Jul 30;140(5):420-433. doi: 10.1161/CIRCULATIONAHA.119.039797. Epub 2019 Jul 29.

PMID:
31356129
9.

Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics.

Seban RD, Nemer JS, Marabelle A, Yeh R, Deutsch E, Ammari S, Moya-Plana A, Mokrane FZ, Gartrell RD, Finkel G, Barker L, Bigorgne AE, Schwartz LH, Saenger Y, Robert C, Dercle L.

Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2298-2310. doi: 10.1007/s00259-019-04411-7. Epub 2019 Jul 25.

PMID:
31346755
10.

Impact of concomitant treatment of non-chronic total occlusion lesions at the time of chronic total occlusion intervention.

Xenogiannis I, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Uretsky B, Krestyaninov O, Khelimskii D, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samady H, Jefferson BK, Patel T, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Gkargkoulas F, Tajti P, Hall AB, Rangan BV, Abdullah S, Banerjee S, Brilakis ES.

Int J Cardiol. 2019 Jul 3. pii: S0167-5273(18)37361-3. doi: 10.1016/j.ijcard.2019.06.077. [Epub ahead of print]

PMID:
31301862
11.

Exposure to breast milk triclosan and parabens and eczema phenotypes at 12 months: A nested case-control study.

Lowe AJ, Wang X, Mueller JF, Abramson MJ, Yeh RY, Erbas B, Dharmage SC, Lodge CJ.

J Allergy Clin Immunol. 2019 Jul 11. pii: S0091-6749(19)30903-0. doi: 10.1016/j.jaci.2019.07.001. [Epub ahead of print] No abstract available.

PMID:
31301372
12.

Left Main Chronic Total Occlusion Percutaneous Coronary Intervention: A Case Series.

Xenogiannis I, Karmpaliotis D, Alaswad K, Basir MB, Yeh RW, Tamez H, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Khatri JJ, Sheikh AM, Malik BA, Greene ME, Abi Rafeh N, Maalouf A, Abou Jaoudeh F, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Gkargkoulas F, Russo J, Hakemi E, Tajti P, Hall AB, Vemmou E, Nikolakopoulos I, Rangan BV, Abdullah S, Banerjee S, Brilakis ES.

J Invasive Cardiol. 2019 Jul;31(7):E220-E225.

13.

Trends in isolated aortic valve replacement in the United States in the early phase of expansion of TAVR.

Kundi H, Cohen DJ, Strom JB, Valsdottir L, Shen C, Choi E, Popma JJ, Yeh RW.

Int J Cardiol. 2019 Oct 1;292:68-72. doi: 10.1016/j.ijcard.2019.06.061. Epub 2019 Jun 22.

PMID:
31255451
14.

Association of Medicaid Expansion With Cardiovascular Mortality.

Khatana SAM, Bhatla A, Nathan AS, Giri J, Shen C, Kazi DS, Yeh RW, Groeneveld PW.

JAMA Cardiol. 2019 Jul 1;4(7):671-679. doi: 10.1001/jamacardio.2019.1651. Erratum in: JAMA Cardiol. 2019 Jul 1;4(7):714.

PMID:
31166575
15.

Etiologies, trends, and predictors of readmission in ST-elevation myocardial infarction patients undergoing multivessel percutaneous coronary intervention.

Tripathi B, Yeh RW, Bavishi CP, Sardar P, Atti V, Mukherjee D, Bashir R, Abbott JD, Giri J, Chatterjee S.

Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28344. [Epub ahead of print]

PMID:
31165573
16.

Intensive care use and mortality among patients with ST elevation myocardial infarction: retrospective cohort study.

Valley TS, Iwashyna TJ, Cooke CR, Sinha SS, Ryan AM, Yeh RW, Nallamothu BK.

BMJ. 2019 Jun 4;365:l1927. doi: 10.1136/bmj.l1927.

17.

Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement.

McCune JS, Quinones CM, Ritchie J, Carpenter PA, van Maarseveen E, Yeh RF, Anasetti C, Boelens JJ, Hamerschlak N, Hassan M, Kang HJ, Kanda Y, Paci A, Perales MA, Shaw PJ, Seewaldt VL, Savani BN, Hsieh A, Poon B, Mohty M, Pulsipher MA, Pasquini M, Dupuis LL.

Biol Blood Marrow Transplant. 2019 May 25. pii: S1083-8791(19)30332-5. doi: 10.1016/j.bbmt.2019.05.021. [Epub ahead of print]

PMID:
31136799
18.

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.

Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, Kim HS, Kimura T, Konishi A, Laschinger J, Leon MB, Magee PFA, Mitsutake Y, Mylotte D, Pocock S, Price MJ, Rao SV, Spitzer E, Stockbridge N, Valgimigli M, Varenne O, Windhoevel U, Yeh RW, Krucoff MW, Morice MC.

Eur Heart J. 2019 Aug 14;40(31):2632-2653. doi: 10.1093/eurheartj/ehz372.

19.

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.

Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, Kim HS, Kimura T, Konishi A, Laschinger J, Leon MB, Magee PFA, Mitsutake Y, Mylotte D, Pocock S, Price MJ, Rao SV, Spitzer E, Stockbridge N, Valgimigli M, Varenne O, Windhoevel U, Yeh RW, Krucoff MW, Morice MC.

Circulation. 2019 Jul 16;140(3):240-261. doi: 10.1161/CIRCULATIONAHA.119.040167. Epub 2019 May 22.

20.

CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor.

Pagni PP, Wolf A, Lo Conte M, Yeh R, Fu G, Liu F, von Herrath M, Coppieters K.

Diabetologia. 2019 Sep;62(9):1727-1729. doi: 10.1007/s00125-019-4893-2. Epub 2019 May 17. No abstract available.

PMID:
31101931
21.

The Hospital Readmissions Reduction Program - Time for a Reboot.

Wadhera RK, Yeh RW, Joynt Maddox KE.

N Engl J Med. 2019 Jun 13;380(24):2289-2291. doi: 10.1056/NEJMp1901225. Epub 2019 May 15. No abstract available.

22.

Putting Theory to the Test.

Strom JB, Yeh RW.

Circ Cardiovasc Interv. 2019 May;12(5):e007953. doi: 10.1161/CIRCINTERVENTIONS.119.007953. No abstract available.

PMID:
31084240
23.

Hospital-Specific Mortality for Acute Myocardial Infarction Versus Emergency Percutaneous Coronary Intervention in New York State.

Nathan AS, Khatana SAM, Yeh RW, Groeneveld PW, Giri J.

JACC Cardiovasc Interv. 2019 May 13;12(9):898-899. doi: 10.1016/j.jcin.2019.02.045. No abstract available.

PMID:
31072516
24.

Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy.

Seban RD, Robert C, Dercle L, Yeh R, Dunant A, Reuze S, Schernberg A, Sun R, Mignot F, Terroir M, Schlumberger M, Haie-Meder C, Chargari C, Deutsch E.

Oncoimmunology. 2019 Mar 6;8(5):e1574197. doi: 10.1080/2162402X.2019.1574197. eCollection 2019.

25.

Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice: An NCDR Registry to Practice Project.

Chau KH, Kennedy KF, Messenger JC, Garratt KN, Maddox TM, Yeh RW, Kirtane AJ.

JAMA Cardiol. 2019 Jun 1;4(6):564-568. doi: 10.1001/jamacardio.2019.0388.

PMID:
31066860
26.

Tumor-induced osteomalacia - Current imaging modalities and a systematic approach for tumor localization.

Rayamajhi SJ, Yeh R, Wong T, Dumeer S, Mittal BR, Remotti F, Chikeka I, Reddy AK.

Clin Imaging. 2019 Jul - Aug;56:114-123. doi: 10.1016/j.clinimag.2019.04.007. Epub 2019 Apr 17. Review.

PMID:
31029010
27.

Reexamination of the chromium-51-labeled posttransfusion red blood cell recovery method.

Francis RO, Mahajan S, Rapido F, La Carpia F, Soffing M, Divgi C, Yeh R, Mintz A, Leslie L, Agrest I, Karafin MS, Ginzburg Y, Shaz BH, Spitalnik SL, Schwartz J, Thomas T, Fu X, Amireault P, Buffet P, Zimring JC, D'Alessandro A, Hod EA.

Transfusion. 2019 Jul;59(7):2264-2275. doi: 10.1111/trf.15310. Epub 2019 Apr 19.

PMID:
31002399
28.

Effect of Public Reporting on the Utilization of Coronary Angiography After Out-of-Hospital Cardiac Arrest.

Nathan AS, Shah RM, Khatana SA, Dayoub E, Chatterjee P, Desai ND, Waldo SW, Yeh RW, Groeneveld PW, Giri J.

Circ Cardiovasc Interv. 2019 Apr;12(4):e007564. doi: 10.1161/CIRCINTERVENTIONS.118.007564.

PMID:
30998398
29.

The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI.

Rozenblum L, Mokrane FZ, Yeh R, Sinigaglia M, Besson F, Seban RD, Chougnet CN, Revel-Mouroz P, Zhao B, Otal P, Schwartz LH, Dercle L.

Abdom Radiol (NY). 2019 Jul;44(7):2474-2493. doi: 10.1007/s00261-019-01994-5. Review.

PMID:
30980115
30.

Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort.

Kundi H, Popma JJ, Reynolds MR, Strom JB, Pinto DS, Valsdottir LR, Shen C, Choi E, Yeh RW.

Eur Heart J. 2019 Jul 14;40(27):2231-2239. doi: 10.1093/eurheartj/ehz187.

PMID:
30977798
31.

Health Insurance and Mobile Health Devices: Opportunities and Concerns.

Raber I, McCarthy CP, Yeh RW.

JAMA. 2019 May 14;321(18):1767-1768. doi: 10.1001/jama.2019.3353. No abstract available.

PMID:
30973573
32.

Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study.

Strom JB, Tamez H, Zhao Y, Valsdottir LR, Curtis J, Brennan JM, Shen C, Popma JJ, Mauri L, Yeh RW.

Am Heart J. 2019 Jun;212:64-71. doi: 10.1016/j.ahj.2019.02.007. Epub 2019 Mar 6.

PMID:
30953936
33.

Erosive pustular dermatosis of the scalp - an Australian perspective: Insights to aid clinical practice.

Yeh R, Polcz M, Wong D.

Australas J Dermatol. 2019 Apr 2. doi: 10.1111/ajd.13042. [Epub ahead of print] Review.

PMID:
30941755
34.

Patient Readmission Rates For All Insurance Types After Implementation Of The Hospital Readmissions Reduction Program.

Ferro EG, Secemsky EA, Wadhera RK, Choi E, Strom JB, Wasfy JH, Wang Y, Shen C, Yeh RW.

Health Aff (Millwood). 2019 Apr;38(4):585-593. doi: 10.1377/hlthaff.2018.05412.

PMID:
30933582
35.

Public Reporting of Percutaneous Coronary Intervention Outcomes: Institutional Costs and Physician Burden.

Wadhera RK, O'Brien CW, Joynt Maddox KE, Ho KKL, Pinto DS, Resnic FS, Shah PB, Yeh RW.

J Am Coll Cardiol. 2019 May 28;73(20):2604-2608. doi: 10.1016/j.jacc.2019.03.014. Epub 2019 Mar 15. No abstract available.

36.

Depression and Angina Among Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention: The OPEN-CTO Registry.

Yeh RW, Tamez H, Secemsky EA, Grantham JA, Sapontis J, Spertus JA, Cohen DJ, Nicholson WJ, Gosch K, Jones PG, Valsdottir LR, Bruckel J, Lombardi WL, Jaffer FA.

JACC Cardiovasc Interv. 2019 Apr 8;12(7):651-658. doi: 10.1016/j.jcin.2018.12.029. Epub 2019 Mar 13.

PMID:
30878475
37.

In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Prior Coronary Artery Bypass Graft Surgery.

Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES.

Circ Cardiovasc Interv. 2019 Mar;12(3):e007338. doi: 10.1161/CIRCINTERVENTIONS.118.007338.

PMID:
30871357
38.

Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism.

Yeh R, Tay YD, Tabacco G, Dercle L, Kuo JH, Bandeira L, McManus C, Leung DK, Lee JA, Bilezikian JP.

Radiology. 2019 May;291(2):469-476. doi: 10.1148/radiol.2019182122. Epub 2019 Mar 5.

PMID:
30835187
39.

Drug-Eluting Stent Implantation and Long-Term Survival Following Peripheral Artery Revascularization.

Secemsky EA, Kundi H, Weinberg I, Schermerhorn M, Beckman JA, Parikh SA, Jaff MR, Mustapha J, Rosenfield K, Yeh RW.

J Am Coll Cardiol. 2019 May 28;73(20):2636-2638. doi: 10.1016/j.jacc.2019.02.020. Epub 2019 Mar 1. No abstract available.

PMID:
30831175
40.

Usefulness of Atherectomy in Chronic Total Occlusion Interventions (from the PROGRESS-CTO Registry).

Xenogiannis I, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Krestyaninov O, Khelimskii D, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samady H, Jefferson BK, Patel T, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Tajti P, Rangan BV, Abdullah S, Banerjee S, Brilakis ES.

Am J Cardiol. 2019 May 1;123(9):1422-1428. doi: 10.1016/j.amjcard.2019.01.054. Epub 2019 Feb 11.

PMID:
30798947
41.

Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion Registry.

Tajti P, Alaswad K, Karmpaliotis D, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky BF, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samady H, Jefferson B, Patel T, Abdullah S, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES.

JACC Cardiovasc Interv. 2019 Feb 25;12(4):346-358. doi: 10.1016/j.jcin.2018.11.019.

PMID:
30784639
42.

Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices.

Secemsky EA, Kundi H, Weinberg I, Jaff MR, Krawisz A, Parikh SA, Beckman JA, Mustapha J, Rosenfield K, Yeh RW.

JAMA Cardiol. 2019 Apr 1;4(4):332-340. doi: 10.1001/jamacardio.2019.0325.

PMID:
30747949
43.
44.

Association of State Medicaid Expansion With Quality of Care and Outcomes for Low-Income Patients Hospitalized With Acute Myocardial Infarction.

Wadhera RK, Bhatt DL, Wang TY, Lu D, Lucas J, Figueroa JF, Garratt KN, Yeh RW, Joynt Maddox KE.

JAMA Cardiol. 2019 Feb 1;4(2):120-127. doi: 10.1001/jamacardio.2018.4577.

PMID:
30649146
45.

Inferior Vena Cava Filters and Mortality: Is It the Underlying Process, the Patient, or the Device?

Secemsky EA, Carroll BJ, Yeh RW.

JAMA Netw Open. 2018 Jul 6;1(3):e180453. doi: 10.1001/jamanetworkopen.2018.0453. No abstract available.

PMID:
30646019
46.

Frequency and Outcomes of Ad Hoc Versus Planned Chronic Total Occlusion Percutaneous Coronary Intervention: Multicenter Experience.

Sandoval Y, Tajti P, Karatasakis A, Burke MN, Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Krestyaninov O, Khelimskii D, Choi JW, Doing AH, Toma C, Wyman RM, Uretsky B, Garcia S, Koutouzis M, Tsiafoutis I, Holper E, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Kandzari DE, Karacsonyi J, Rangan BV, Thompson C, Banerjee S, Brilakis ES.

J Invasive Cardiol. 2019 May;31(5):133-139. Epub 2019 Jan 15.

47.

SCOT-HEART: Does it live up to the PROMISE?

Strom JB, Shen C, Yeh RW.

J Cardiovasc Comput Tomogr. 2019 May - Jun;13(3):48-50. doi: 10.1016/j.jcct.2019.01.008. Epub 2019 Jan 4. No abstract available.

PMID:
30638707
48.

Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry.

Secemsky EA, Ferro EG, Rao SV, Kirtane A, Tamez H, Zakroysky P, Wojdyla D, Bradley SM, Cohen DJ, Yeh RW.

JAMA Cardiol. 2019 Feb 1;4(2):110-118. doi: 10.1001/jamacardio.2018.4472.

PMID:
30624549
49.

Reply: Trends in Isolated Surgical Aortic Valve Replacement.

Kundi H, Yeh RW.

JACC Cardiovasc Interv. 2019 Jan 14;12(1):108-109. doi: 10.1016/j.jcin.2018.11.002. No abstract available.

PMID:
30621970
50.

The DAPT Score in Sweden: Successful Validation, Flawed Interpretation.

Yeh RW, Kereiakes DJ, Secemsky EA, Steg PG, Mauri L.

J Am Coll Cardiol. 2019 Jan 8;73(1):113-114. doi: 10.1016/j.jacc.2018.10.053. No abstract available.

PMID:
30621941

Supplemental Content

Support Center